Dear Speaker Pelosi and Leaders McConnell, McCarthy, and Schumer: I write regarding prospective federal intervention to support the airline, travel, and other targeted industries impacted by the coronavirus (COVID-19) epidemic. […]
Letters + Comments
Notice of Benefit and Payment Parameters for 2021
The National Health Council (NHC) appreciates the opportunity to comment on the Centers for Medicare & Medicaid Services’ (CMS’) Proposed Rule entitled, “HHS Notice of Benefit and Payment Parameters for […]
Office of Minority Health and Health Equity (OMHHE) Strategic Priorities Public Docket
The National Health Council (NHC) appreciates the opportunity to provide comments as the Food and Drug Administration’s (FDA’s) establishes its Office of Minority Health and Health Equity (OMHHE) Strategic Priorities […]
Patient-Focused Drug Development Guidance: Incorporating Clinical Outcome Assessments into Endpoints for Regulatory Decision-Making; Public Workshop
The National Health Council (NHC) is pleased to provide comments on the Food and Drug Administration’s (FDA) discussion documents related to Guidance 4: “Incorporating Clinical Outcome Assessments into Endpoints for […]
Health and Human Services’ Transparency in Coverage Proposed Rule
The National Health Council (NHC) appreciates the Opportunity to comment on the Department of Health and Human Services’ (HHS) Transparency in Coverage proposed rule. The NHC has long advocated for […]
Medicare and State Healthcare Programs: Fraud and Abuse; Revisions To Safe Harbors Under the Anti-Kickback Statute, and Civil Monetary Penalty Rules Regarding Beneficiary Inducements
The National Health Council appreciates the opportunity to comment on the proposed rule released by the Office of the Inspector General (OIG) revising safe harbors under the Anti-Kickback Statute (AKS) […]
Centers for Medicare & Medicaid Services’ (CMS’) Proposed Medicare Program Rule; Modernizing and Clarifying the Physician Self-Referral Regulations
The National Health Council appreciates the opportunity to comment on the Centers for Medicare & Medicaid Services’ (CMS’) proposed rule modernizing and clarifying the physician self-referral (Stark Law) regulations. Founded […]
Patient-Focused Drug Development: Methods to Identify What Is Important to Patients; Draft Guidance for Industry, Food and Drug Administration Staff, and Other Stakeholders
The National Health Council (NHC) is pleased to provide comments on the Food and Drug Administration’s solicitation for comments Patient-Focused Drug Development: Methods to Identify What Is Important to Patients; […]
Congressional Efforts to Address Drug Pricing – Prescription Drug Pricing Reduction Act (PDPRA)
The National Health Council (NHC) appreciates this opportunity to provide feedback on Congressional efforts to address drug pricing including H.R. 3, the Lower Drug Costs Now Act, and S. 2543, […]
Letter to Representatives DeGette & Upton on the “Cures 2.0” Initiative
Dear Representative DeGette and Representative Upton: The National Health Council (NHC) appreciates this opportunity to provide feedback on your work to help advance medical research and foster medical innovations in […]